Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels.
El Shamieh. Said S; Ndiaye. Ndeye Coumba NC; Stathopoulou. Maria G MG; Murray. Helena A HA; Masson. Christine C; Lamont. John V JV; Fitzgerald. Peter P; Benetos. Athanase A; Visvikis-Siest. Sophie S
Key Findings
- rs6046A in F7 is associated with lower blood pressure
- rs5355T in SELE is associated with lower diastolic blood pressure
- The two variants interact to further affect blood pressure
- rs6046A correlates with higher NAMPT mRNA levels
- Higher NAMPT expression is linked to increased LL‑37 gene expression
- LL‑37 expression is positively associated with systolic blood pressure, accounting for ~4% of its variation
Practical Outcomes
- For most biohackers, the main takeaway is that these genetic markers and LL‑37 levels have a modest influence on blood pressure, but there’s no direct intervention suggested. If you’re interested in personalized health, genetic testing for these variants could provide a tiny piece of the blood pressure puzzle, yet lifestyle and proven medical strategies remain far more impactful. More research is needed before considering LL‑37 modulation as a blood‑pressure strategy.
Summary
The study found that two common genetic variants, one in the F7 gene and another in the SELE gene, each lower blood pressure and together have a bigger effect. The F7 variant also raises levels of a protein called NAMPT, which in turn is linked to higher expression of the antimicrobial peptide LL‑37. Higher LL‑37 levels were modestly associated with higher systolic blood pressure, explaining about 4% of its variation. These results suggest a genetic‑inflammation link to blood pressure but don’t give a clear way to change it.
Abstract
Although numerous genetic studies have been performed, only 0.9% of blood pressure phenotypic variance has been elucidated. This phenomenon could be partially due to epistatic interactions. Our aim was to identify epistatic interaction(s) associated with blood pressure levels in a pre-planned two-phase approach. In a discovery cohort composed of 3,600 French individuals, we found rs6046A allele in F7 associated with decreased blood pressure levels (P≤3.7×10(-3)) and rs5355T allele in SELE associated with decreased diastolic blood pressure levels (P = 5×10(-3)). Both variants interacted in order to influence blood pressure levels (P≤0.048). This interaction was replicated with systolic blood pressure in 4,620 additional European individuals (P = 0.03). Similarly, in this replication cohort, rs6046A was associated with decreased blood pressure levels (P≤8.5×10(-4)). Furthermore, in peripheral blood mononuclear cells of a subsample of 90 supposed healthy individuals, we found rs6046A positively associated with NAMPT mRNA levels (P≤9.1×10(-5)), suggesting an eventual involvement of NAMPT expression in blood pressure regulation. Confirming this hypothesis, further transcriptomic analyses showed that increased NAMPT mRNA levels were positively correlated with ICAM1, SELL, FPR1, DEFA1-3, and LL-37 genes expression (P≤5×10(-3)). The last two mRNA levels were positively associated with systolic blood pressure levels (P≤0.01) and explained 4% of its phenotypic variation. These findings reveal the importance of epistatic interactions in blood pressure genetics and give new insights for the role of inflammation in its complex regulation.
Study Information
pubmed
2012
2012-07-18T00:00:00.000Z
10.1371/journal.pone.0040777
10
49